We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$83.2B
AUM Growth
+$1.08B
Cap. Flow
-$819M
Cap. Flow %
-0.99%
Top 10 Hldgs %
34.54%
Holding
3,151
New
709
Increased
920
Reduced
837
Closed
626

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.06B
2
UNH icon
UnitedHealth
UNH
+$935M
3
UBER icon
Uber
UBER
+$426M
4
BA icon
Boeing
BA
+$312M
5
CRM icon
Salesforce
CRM
+$309M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Consumer Discretionary 14.92%
3 Healthcare 12.54%
4 Financials 8.46%
5 Industrials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAP icon
551
Credicorp
BAP
$30.9B
$18.8M 0.02%
102,751
+40,769
+66% +$7.62M
GEHC icon
552
GE HealthCare
GEHC
$27.6B
$18.8M 0.02%
240,713
+44,180
+22% +$3.76M
CVNA icon
553
Carvana
CVNA
$43.3B
$18.7M 0.02%
460,665
+405,865
+741% +$18.2M
SAIC icon
554
Saic
SAIC
$5.03B
$18.7M 0.02%
+167,240
New +$22.1M
ICLR icon
555
Icon
ICLR
$12.8B
$18.6M 0.02%
+88,739
New +$20.7M
ADC icon
556
Agree Realty
ADC
$9.68B
$18.5M 0.02%
261,974
+60,768
+30% +$4.52M
ITRI icon
557
Itron
ITRI
$3.73B
$18.4M 0.02%
169,398
+1,594
+0.9% +$178K
GDX icon
558
VanEck Gold Miners ETF
GDX
$23B
$18.4M 0.02%
541,699
-17,696
-3% -$679K
JNPR
559
DELISTED
Juniper Networks
JNPR
$18.3M 0.02%
488,761
-405,706
-45% -$15.3M
GCO icon
560
Genesco
GCO
$396M
$18.3M 0.02%
428,143
+95,195
+29% +$3.13M
SBUX icon
561
PUT
Starbucks
SBUX
$118B
$18.3M 0.02%
200,000
-606,000
-75% -$58.6M
ARCB icon
562
ArcBest
ARCB
$3.44B
$18.2M 0.02%
195,532
-70,902
-27% -$7.5M
ACAD icon
563
Acadia Pharmaceuticals
ACAD
$4.25B
$18.2M 0.02%
993,593
-195,019
-16% -$3.15M
PANW icon
564
Palo Alto Networks
PANW
$264B
$18.2M 0.02%
100,000
-275,926
-73% -$52.1M
AMD icon
565
PUT
Advanced Micro Devices
AMD
$851B
$18.2M 0.02%
150,400
+29,700
+25% +$4.27M
MLM icon
566
Martin Marietta Materials
MLM
$33.6B
$18.1M 0.02%
35,112
-173,990
-83% -$98.7M
BDX icon
567
Becton Dickinson
BDX
$43.1B
$18.1M 0.02%
79,610
+22,429
+39% +$5.18M
FMX icon
568
Fomento Económico Mexicano
FMX
$43.3B
$18M 0.02%
210,851
-61,747
-23% -$5.73M
SLNO
569
DELISTED
Soleno Therapeutics
SLNO
$18M 0.02%
399,849
+152,010
+61% +$7.88M
AMED
570
DELISTED
Amedisys
AMED
$17.7M 0.02%
194,603
-147,343
-43% -$13.5M
ADP icon
571
PUT
Automatic Data Processing
ADP
$100B
$17.6M 0.02%
60,000
-60,000
-50% -$17.7M
DFTX
572
Definium Therapeutics
DFTX
$5.73B
$17.4M 0.02%
2,501,391
+213,526
+9% +$1.47M
MBB icon
573
iShares MBS ETF
MBB
$39B
$17.4M 0.02%
189,300
+29,900
+19% +$2.78M
HRI icon
574
Herc Holdings
HRI
$5.43B
$17.3M 0.02%
91,613
-194,891
-68% -$39.3M
BNTX icon
575
BioNTech
BNTX
$22.6B
$17.1M 0.02%
150,157
+37,177
+33% +$4.24M

Similar funds

Marshall Wace's Q4 2024 Portfolio in Review

As of Q4 2024, Marshall Wace held 3,151 positions worth $83.2B, up 1.3% from $82.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace's Q4 2024 filing shows 709 new, 920 increased, 837 reduced and 626 closed positions. Its largest new stake was Boeing: 1,988,038 shares worth $352M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.09B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q4 2024 buy was Boeing: 1,988,038 shares worth $352M.
  • Marshall Wace added most to Apple in Q4 2024, an estimated $1.06B increase.
  • Marshall Wace's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.09B.
  • Marshall Wace fully exited GE Vernova in Q4 2024, selling an estimated $439M.
  • Marshall Wace's ten largest holdings make up 35% of its $83.2B portfolio in Q4 2024.
  • Marshall Wace opened 709 new positions and closed 626 in Q4 2024.
  • Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $83.2B.

Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.